Accelrys has introduced its Biological Registration application, a multi-entity, enterprise-scalable registration system for biological entities.
The offering comprises a fully functional, biological registration database, with out-of-the-box templates for eight major biological entities: Yeast, Cell Line, DNA, Protein, Plasmid, Vaccine, Antibody and siRNA. Utilising a flexible and extensible knowledge model, with automatic relationship cross-referencing, organisations can quickly configure the solution to support their unique scientific research and development processes, supported by the underlying business rules and workflows in Accelrys Pipeline Pilot.
The system, which integrates with existing infrastructure, can be accessed through standard desktop clients, web-based portals, or electronic lab notebooks (ELNs), and is suitable for use by scientists, research managers, executives, and corporate users involved in IT, legal, regulatory, manufacturing, or health and safety operations.
Accelrys Biological Registration is the result of a three-year collaboration with several of the world's leading bio-pharmaceutical companies including Abbott Laboratories and Merck. By working as a Special Interest Group (SIG) with these different organisations, a comprehensive foundation for maximising the value of biological research has been developed. When implemented, the application significantly reduces the risk inherent in failing to register biological intellectual property while enabling knowledge sharing among biology and other research scientists.